{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T05:07:22Z","timestamp":1772082442083,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:00:00Z","timestamp":1527724800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s11916-018-0695-3","type":"journal-article","created":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T08:16:38Z","timestamp":1527754598000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Labeling Morphine Milligram Equivalents on Opioid Packaging: a Potential Patient Safety Intervention"],"prefix":"10.1007","volume":"22","author":[{"given":"Alexander B.","family":"Stone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard D.","family":"Urman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael C.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,31]]},"reference":[{"key":"695_CR1","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","volume":"315","author":"D Dowell","year":"2016","unstructured":"\u2022\u2022 Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016. JAMA. 2016;315:1624\u201345. The most recent CDC guidelines for opioid prescribing.","journal-title":"JAMA"},{"key":"695_CR2","unstructured":"(2017) State census data 2016. https:\/\/www.census.gov\/data\/tables\/2016\/demo\/popest\/state\u2013total.html ."},{"key":"695_CR3","doi-asserted-by":"crossref","first-page":"E503","DOI":"10.36076\/ppj.2014\/17\/E503","volume":"17","author":"P Gulur","year":"2014","unstructured":"\u2022 Gulur P, Williams L, Chaudhary S, Koury K, Jaff M. Opioid tolerance\u2014a predictor of increased length of stay and higher readmission rates. Pain Physician. 2014;17:E503\u20137. A well-executed large retrospective study identifying predictors of increased complications.","journal-title":"Pain Physician"},{"key":"695_CR4","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/SLA.0000000000001945","volume":"265","author":"CE Cauley","year":"2017","unstructured":"Cauley CE, Anderson G, Haynes AB, Menendez M, Bateman BT, Ladha K. Predictors of in-hospital postoperative opioid overdose after major elective operations: a nationally representative cohort study. Ann Surg. 2017;265:702\u20138.","journal-title":"Ann Surg"},{"key":"695_CR5","doi-asserted-by":"publisher","first-page":"162","DOI":"10.2146\/ajhp160208","volume":"74","author":"B Meisenberg","year":"2017","unstructured":"Meisenberg B, Ness J, Rao S, Rhule J, Ley C. Implementation of solutions to reduce opioid-induced oversedation and respiratory depression. Am J Heal-Syst Pharm Ajhp Off J Am Soc Heal-Syst Pharm. 2017;74:162\u20139.","journal-title":"Am J Heal-Syst Pharm Ajhp Off J Am Soc Heal-Syst Pharm"},{"key":"695_CR6","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.36076\/ppj.2017.s111","volume":"20","author":"AD Kaye","year":"2017","unstructured":"\u2022 Kaye AD, Jones MR, Kaye AM, Ripoll JG, Galan V, Beakley BD, et al. Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse: Part 1. Pain Physician. 2017;20:S93\u2013S109. A comprehensive review of strategies to reduce the impact of the opioid epidemic.","journal-title":"Pain Physician"},{"key":"695_CR7","first-page":"S111","volume":"20","author":"AD Kaye","year":"2017","unstructured":"Kaye AD, Jones MR, Kaye AM, Ripoll JG, Jones DE, Galan V, et al. Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse (Part 2). Pain Physician. 2017;20:S111\u201333.","journal-title":"Pain Physician"},{"key":"695_CR8","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1056\/NEJMsr1601307","volume":"374","author":"RM Califf","year":"2016","unstructured":"Califf RM, Woodcock J, Ostroff S. A proactive response to prescription opioid abuse. N Engl J Med. 2016;374:1480\u20135.","journal-title":"N Engl J Med"},{"key":"695_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5581","volume":"347","author":"M McCarthy","year":"2013","unstructured":"McCarthy M. FDA to tighten labeling on long acting opioids. BMJ. 2013;347:f5581.","journal-title":"BMJ"},{"key":"695_CR10","unstructured":"Federal Drug Administration. FDA requires strong warnings for opioid analgesics, prescription opioid cough products, and benzodiazepine labeling related to serious risks and death from combined use. Available at: ( https:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/ucm518697.htm ). Accessed January 15, 2018."},{"key":"695_CR11","unstructured":"Centers for Medicare and Medicaid Services. Opioid oral morphine milligram equivalent (MME) conversion factors. Available at: https:\/\/www.cms.gov\/Medicare\/Prescription-Drug-Coverage\/PrescriptionDrugCovContra\/Downloads\/Opioid-Morphine-EQ-Conversion-Factors-Aug-2017.pdf . Accessed January 15, 2018."},{"key":"695_CR12","unstructured":"Turn the tide. Treatment options: when to decide to prescribe opioids. http:\/\/turnthetiderx.org\/treatment\/ . Accessed January 15, 2018."},{"key":"695_CR13","doi-asserted-by":"publisher","unstructured":"Ryland K. Using visual prompts to aid analgesia prescribing. BMJ Qual Improv Rep. 2015;4:1 https:\/\/doi.org\/10.1136\/bmjquality.u210015.w4138 .","DOI":"10.1136\/bmjquality.u210015.w4138"},{"key":"695_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.anclin.2017.01.015","volume":"35","author":"R Saba","year":"2017","unstructured":"Saba R, Kaye AD, Urman RD. Pharmacogenomics in pain management. Anesthesiol Clin. 2017;35:295\u2013304.","journal-title":"Anesthesiol Clin"},{"key":"695_CR15","doi-asserted-by":"publisher","unstructured":"Rennick A, Atkinson T, Cimino NM, Strassels SA, McPherson ML, Fudin J. Variability in opioid equivalence calculations. Pain Med Malden Mass. 2015; https:\/\/doi.org\/10.1111\/pme.12920 .","DOI":"10.1111\/pme.12920"},{"key":"695_CR16","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/pds.3945","volume":"25","author":"S Nielsen","year":"2016","unstructured":"\u2022 Nielsen S, Degenhardt L, Hoban B, Gisev N. A synthesis of oral morphine equivalents (OME) for opioid utilisation studies. Pharmacoepidemiol Drug Saf. 2016;25:733\u20137. A thoughtful analysis of the advantages and pitfalls of opioid equianalgesic conversions.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"695_CR17","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1056\/NEJMp1614972","volume":"376","author":"BM Psaty","year":"2017","unstructured":"Psaty BM, Merrill JO. Addressing the opioid epidemic\u2014opportunities in the postmarketing setting. N Engl J Med. 2017;376:1502\u20134.","journal-title":"N Engl J Med"},{"key":"695_CR18","unstructured":"Code of Federal Regulations. 1302 -- Labeling Packag Requir Control Substance. Available at: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=1302.03 . Last accessed January 15, 2018."},{"key":"695_CR19","unstructured":"US Health and Human Services. The opioid epidemic: by the numbers. Available at: ( https:\/\/www.hhs.gov\/sites\/default\/files\/Factsheet-opioids-061516.pdf ). Accessed January 15, 2018."},{"key":"695_CR20","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1345\/aph.1H582","volume":"41","author":"W Shrank","year":"2007","unstructured":"Shrank W, Avorn J, Rolon C, Shekelle P. Effect of content and format of prescription drug labels on readability, understanding, and medication use: a systematic review. Ann Pharmacother. 2007;41:783\u2013801.","journal-title":"Ann Pharmacother"},{"key":"695_CR21","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1007\/s11606-016-3816-x","volume":"31","author":"MS Wolf","year":"2016","unstructured":"Wolf MS, Davis TC, Curtis LM, Bailey SC, Knox JP, Bergeron A, et al. A patient-centered prescription drug label to promote appropriate medication use and adherence. J Gen Intern Med. 2016;31:1482\u20139.","journal-title":"J Gen Intern Med"},{"key":"695_CR22","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1177\/0018720816664824","volume":"58","author":"T Endestad","year":"2016","unstructured":"Endestad T, Wortinger LA, Madsen S, Hortemo S. Package design affects accuracy recognition for medications. Hum Factors. 2016;58:1206\u201316.","journal-title":"Hum Factors"},{"key":"695_CR23","doi-asserted-by":"crossref","unstructured":"Abrecht CR, Brovman EY, Greenberg P, Song E, Rathmell JP, Urman RD. A contemporary medicolegal analysis of outpatient medication management in chronic pain. Anesth Analg. 2017;125(5):1761\u20131768.","DOI":"10.1213\/ANE.0000000000002499"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11916-018-0695-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-018-0695-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-018-0695-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T19:51:21Z","timestamp":1661370681000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11916-018-0695-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,31]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["695"],"URL":"https:\/\/doi.org\/10.1007\/s11916-018-0695-3","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,31]]},"assertion":[{"value":"31 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Alexander B. Stone, Alan D. Kaye, and Michael C. Grant declare no conflict of interest. Richard D. Urman reports research funding from Mallinckrodt, Merck and Medtronic for unrelated research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"46"}}